Wanfu Xu

1.8k total citations
60 papers, 1.3k citations indexed

About

Wanfu Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Wanfu Xu has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Wanfu Xu's work include Cancer, Hypoxia, and Metabolism (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Inflammasome and immune disorders (6 papers). Wanfu Xu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Inflammasome and immune disorders (6 papers). Wanfu Xu collaborates with scholars based in China, United Kingdom and United States. Wanfu Xu's co-authors include Sitang Gong, Lanlan Geng, Yang Cheng, Junhong Zhao, Yun Zhu, Peiyu Chen, Fan Deng, Min Yang, Fangyin Zeng and Kejian Zou and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Journal of Cell Science.

In The Last Decade

Wanfu Xu

60 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanfu Xu China 21 706 386 263 245 242 60 1.3k
Hong Shu China 22 780 1.1× 309 0.8× 245 0.9× 134 0.5× 177 0.7× 94 1.4k
Guanglong Dong China 24 874 1.2× 601 1.6× 378 1.4× 197 0.8× 232 1.0× 76 1.6k
Chunxiang Li China 18 524 0.7× 232 0.6× 327 1.2× 232 0.9× 261 1.1× 83 1.3k
Yang Xu China 24 812 1.2× 449 1.2× 282 1.1× 166 0.7× 349 1.4× 87 1.7k
Jiangchao Li China 22 963 1.4× 553 1.4× 368 1.4× 165 0.7× 157 0.6× 72 1.6k
Ji‐Min Zhu China 25 1.0k 1.5× 562 1.5× 262 1.0× 173 0.7× 235 1.0× 58 1.7k
Feng Jiang China 25 1.2k 1.7× 597 1.5× 198 0.8× 244 1.0× 121 0.5× 70 1.7k
Wenting Xu China 18 872 1.2× 412 1.1× 424 1.6× 168 0.7× 206 0.9× 46 1.6k
Yanfei Jia China 24 890 1.3× 385 1.0× 345 1.3× 210 0.9× 195 0.8× 102 1.6k

Countries citing papers authored by Wanfu Xu

Since Specialization
Citations

This map shows the geographic impact of Wanfu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanfu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanfu Xu more than expected).

Fields of papers citing papers by Wanfu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanfu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanfu Xu. The network helps show where Wanfu Xu may publish in the future.

Co-authorship network of co-authors of Wanfu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanfu Xu. A scholar is included among the top collaborators of Wanfu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanfu Xu. Wanfu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, Linlin Li, Wanfu Xu, et al.. (2025). Identification of Gingival Inflammation Surface Image Features Using Intraoral Scanning and Deep Learning. International Dental Journal. 75(3). 2104–2114. 4 indexed citations
2.
He, Zhibin, et al.. (2025). Enhancing intestinal epithelial microtubule stability could alleviate IBD symptoms. Cell Communication and Signaling. 23(1). 263–263. 1 indexed citations
3.
Li, Xiang, Xiaoyan Zhang, Zhi‐Ling Li, et al.. (2024). GZMA suppressed GPX4-mediated ferroptosis to improve intestinal mucosal barrier function in inflammatory bowel disease. Cell Communication and Signaling. 22(1). 9 indexed citations
4.
Xie, Jing, Fangfang Xie, Lanlan Geng, et al.. (2024). Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis. Frontiers in Pharmacology. 15. 1409001–1409001. 2 indexed citations
5.
Fu, Ming, Nini Chen, Yanhe Zhou, et al.. (2023). Jatrorrhizine Suppresses Murine-Norovirus-Triggered N-GSDMD-Dependent Pyroptosis in RAW264.7 Macrophages. Vaccines. 11(1). 164–164. 6 indexed citations
6.
Wang, Hongli, Jing Xie, Lu Ren, et al.. (2023). Age Is a Risk Factor for Gastroscopy-Assisted Capsule Endoscopy in Children. The Turkish Journal of Gastroenterology. 35(1). 41–47. 1 indexed citations
7.
Wang, Yaodong, Xiaorong Zhou, Kejian Zou, et al.. (2021). Monocarboxylate Transporter 4 Triggered Cell Pyroptosis to Aggravate Intestinal Inflammation in Inflammatory Bowel Disease. Frontiers in Immunology. 12. 644862–644862. 22 indexed citations
8.
Xu, Zhaohui, Ruitao Liu, Ling Huang, et al.. (2020). CD147 Aggravated Inflammatory Bowel Disease by Triggering NF‐κB‐Mediated Pyroptosis. BioMed Research International. 2020(1). 5341247–5341247. 21 indexed citations
9.
Wang, Hongli, Jun Ye, Ruitao Liu, et al.. (2020). Clinical Significance of CD147 in Children with Inflammatory Bowel Disease. BioMed Research International. 2020(1). 7647181–7647181. 5 indexed citations
10.
Li, Musheng, Junhong Zhao, Guanhua Chen, et al.. (2020). Mast cells-derived MiR-223 destroys intestinal barrier function by inhibition of CLDN8 expression in intestinal epithelial cells. Biological Research. 53(1). 12–12. 69 indexed citations
11.
Chen, Peiyu, Hongli Wang, Junhong Zhao, et al.. (2020). Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells. Biomedicine & Pharmacotherapy. 130. 110472–110472. 16 indexed citations
12.
Xu, Wanfu, Fangyin Zeng, Songyu Li, et al.. (2019). Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment. Journal of Experimental & Clinical Cancer Research. 38(1). 114–114. 44 indexed citations
13.
He, Liying, Hongli Wang, Lanlan Geng, et al.. (2018). Evaluation of Monocarboxylate Transporter 4 in Inflammatory Bowel Disease and Its Potential Use as a Diagnostic Marker. Disease Markers. 2018. 1–6. 13 indexed citations
14.
Xu, Wanfu, Liying He, Chunhong Jia, et al.. (2018). A far-red-emissive AIE active fluorescent probe with large stokes shift for detection of inflammatory bowel disease in vivo. Journal of Materials Chemistry B. 6(5). 809–815. 24 indexed citations
15.
Xu, Wanfu, Fangyin Zeng, Songyu Li, et al.. (2018). Crosstalk of protein kinase C ε with Smad2/3 promotes tumor cell proliferation in prostate cancer cells by enhancing aerobic glycolysis. Cellular and Molecular Life Sciences. 75(24). 4583–4598. 29 indexed citations
16.
Cheng, Yang, Hang Zheng, Biao Wang, et al.. (2017). Sorafenib and fluvastatin synergistically alleviate hepatic fibrosis via inhibiting the TGFβ1/Smad3 pathway. Digestive and Liver Disease. 50(4). 381–388. 18 indexed citations
17.
Xiong, Jing, Yadong Wang, Wanfu Xu, et al.. (2016). Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice. Scientific Reports. 6(1). 34079–34079. 9 indexed citations
18.
19.
Fan, Helen G. Mar, I. Chemerynsky, Qilong Yi, et al.. (2009). Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study. Annals of Oncology. 21(5). 983–987. 51 indexed citations
20.
Fan, Helen G. Mar, et al.. (2008). The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psycho-Oncology. 18(2). 156–161. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Shu Breakdown of academic impact, for papers by Guanglong Dong Breakdown of academic impact, for papers by Chunxiang Li Breakdown of academic impact, for papers by Yang Xu Breakdown of academic impact, for papers by Jiangchao Li Breakdown of academic impact, for papers by Ji‐Min Zhu Breakdown of academic impact, for papers by Feng Jiang Breakdown of academic impact, for papers by Wenting Xu Breakdown of academic impact, for papers by Yanfei Jia
Rankless by CCL
2026